Cargando…

Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders

Experimental evidence points out that the activation of the endocannabinoid system induces neuroprotective effects and reduces mood disorders. In the hippocampus of patients with mesial temporal lobe epilepsy (MTLE), studies indicated augmented cannabinoid 1 receptor (CB(1)R) binding, in spite of it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocha, Luisa, Cinar, Resat, Guevara-Guzmán, Rosalinda, Alonso-Vanegas, Mario, San-Juan, Daniel, Martínez-Juárez, Iris, Castañeda-Cabral, José Luis, Carmona-Cruz, Francia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218130/ https://www.ncbi.nlm.nih.gov/pubmed/32435186 http://dx.doi.org/10.3389/fnbeh.2020.00052

Ejemplares similares

GABAergic Alterations in Neocortex of Patients with Pharmacoresistant Temporal Lobe Epilepsy Can Explain the Comorbidity of Anxiety and Depression: The Potential Impact of Clinical Factors
por: Rocha, Luisa, et al.
Publicado: (2015)

Drug-Resistant Temporal Lobe Epilepsy Alters the Expression and Functional Coupling to Gαi/o Proteins of CB1 and CB2 Receptors in the Microvasculature of the Human Brain
por: Nuñez-Lumbreras, María de los Ángeles, et al.
Publicado: (2021)

‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy
por: Grote, Alexander, et al.
Publicado: (2022)

Cannabinoids, Endocannabinoids and Sleep
por: Kesner, Andrew J., et al.
Publicado: (2020)

Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
por: Zawatsky, Charles N., et al.
Publicado: (2020)

Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy
por: Bruxel, Estela M., et al.
Publicado: (2021)

Effects of Surgical Side and Site on Mood and Behavior Outcome in Children with Pharmacoresistant Epilepsy
por: Andresen, Elizabeth N., et al.
Publicado: (2014)

The Endocannabinoid System, Cannabinoids, and Pain
por: Fine, Perry G., et al.
Publicado: (2013)

Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Molecular Advances on Cannabinoid and Endocannabinoid Research
por: Meccariello, Rosaria
Publicado: (2023)

Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids
por: Gunduz-Cinar, Ozge, et al.
Publicado: (2016)

Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
por: Cabral, Guy A., et al.
Publicado: (2015)

The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
por: Kwan Cheung, Keith A., et al.
Publicado: (2019)

Association between Quantitative Electroencephalogram Frequency Composition and Post-Surgical Evolution in Pharmacoresistant Temporal Lobe Epilepsy Patients
por: Valdés Sedeño, Raúl Roberto, et al.
Publicado: (2019)

Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities
por: Chen, Fan, et al.
Publicado: (2019)

Endocannabinoids and Precision Medicine for Mood Disorders and Suicide
por: Pinna, Graziano
Publicado: (2021)

Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy
por: El-Azab, Mona F, et al.
Publicado: (2022)

Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020)

FALSE PHARMACORESISTANCE – A TRUE PROBLEM
por: Bašić, Silvio, et al.
Publicado: (2021)

Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
por: Cherkasova, Viktoriia, et al.
Publicado: (2021)

Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research
por: Maccarrone, Mauro
Publicado: (2022)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
por: Hasbi, Ahmed, et al.
Publicado: (2023)

Alcohol Binge-Induced Cardiovascular Dysfunction Involves Endocannabinoid–CB1-R Signaling
por: Paloczi, Janos, et al.
Publicado: (2019)

The endocannabinoid system promotes hepatocyte progenitor cell proliferation and maturation by modulating cellular energetics
por: Mukhopadhyay, Bani, et al.
Publicado: (2023)

Vagal nerve stimulation for pharmacoresistant epilepsy in children
por: Hauptman, Jason S., et al.
Publicado: (2012)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Cholesterol as a modulator of cannabinoid receptor CB(2) signaling
por: Yeliseev, Alexei, et al.
Publicado: (2021)

Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation
por: Iring, András, et al.
Publicado: (2013)

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
por: Zou, Shenglong, et al.
Publicado: (2018)

Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
por: Ambrose, Tim, et al.
Publicado: (2019)

Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions 
por: Spanagel, Rainer
Publicado: (2020)

New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence
por: Saravia, Rocio, et al.
Publicado: (2021)

Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy
por: Xiao, Jie, et al.
Publicado: (2023)

Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
por: Dochez-Arnault, J., et al.
Publicado: (2023)

The endocannabinoid system in the amygdala and modulation of fear
por: Gunduz-Cinar, Ozge
Publicado: (2021)

Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling
por: Tam, Joseph, et al.
Publicado: (2017)

Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder
por: Vyskocilova, Jana, et al.
Publicado: (2016)

Pharmacoresistant seizures and IDH mutation in low-grade gliomas
por: Correia, Carlos Eduardo, et al.
Publicado: (2021)

Pharmacoresistant Abdominal Seizures in Symptomatic Localization-Related Epilepsy
por: Tushar, Vadakke Puthanveetil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8t7nifmq9qdslqhf9e5qulakqa